article thumbnail

Hematology Board Meeting Summary | Spring 2025

ABIM

Topics that came up in discussion included concerns around limited clinical trial access for patients in underserved populations, escalating costs and insurance challenges, such as shifting coverage policies. Learn More Subscribe to the ABIM Blog to stay on top of the latest news.